BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 3885017)

  • 1. Mutagenicity of pyrene in Salmonella.
    Matijasević Z; Zeiger E
    Mutat Res; 1985 Apr; 142(4):149-52. PubMed ID: 3885017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction with microsomal lipid as a major factor responsible for S9-mediated inhibition of 1,8-dinitropyrene mutagenicity.
    Shah AB; Combes RD; Rowland IR
    Mutat Res; 1991 Jul; 249(1):93-104. PubMed ID: 2067546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method.
    Araki A; Kamigaito N; Sasaki T; Matsushima T
    Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selenium inhibition of benzo[a]pyrene, 3-methylcholanthrene, and 3-methylcholanthrylene mutagenicity in Salmonella typhimurium strains TA98 and TA100.
    Prasanna P; Jacobs MM; Yang SK
    Mutat Res; 1987 Feb; 190(2):101-5. PubMed ID: 3547113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic formation of pyrenequinones as enhancing agents of mutagenicity in Salmonella.
    Okamoto H; Yoshida D
    Cancer Lett; 1981 Jan; 11(3):215-20. PubMed ID: 7018664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1-nitropyrene.
    Fifer EK; Howard PC; Heflich RH; Beland FA
    Mutagenesis; 1986 Nov; 1(6):433-8. PubMed ID: 3331683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of mutagenicity of trioxane and dioxolane in Salmonella typhimurium.
    Kowalski Z; Spiechowicz E; Barański B
    Mutat Res; 1984 Jun; 136(3):169-71. PubMed ID: 6377055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity studies on fenitrothion in bacteria and mammalian cells.
    Hara M; Kogiso S; Yamada F; Kawamoto M; Yoshitake A; Miyamoto J
    Mutat Res; 1989 Jan; 222(1):53-61. PubMed ID: 2643032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97.
    Sakai M; Yoshida D; Mizusaki S
    Mutat Res; 1985; 156(1-2):61-7. PubMed ID: 3889628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation and biotransformation of 1-nitropyrene in liver, lung and nasal tissue of rats.
    Bond JA
    Mutat Res; 1983 Dec; 124(3-4):315-24. PubMed ID: 6361542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propyldazine is mutagenic in Salmonella typhimurium and Escherichia coli: distinct specificity for strains TA1537 and TA97.
    Glatt H; Oesch F
    Teratog Carcinog Mutagen; 1985; 5(5):339-45. PubMed ID: 2867616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
    Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
    Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenicity of 2,6-dinitrotoluene and its metabolites, and their related compounds in Salmonella typhimurium.
    Sayama M; Mori M; Shirokawa T; Inoue M; Miyahara T; Kozuka H
    Mutat Res; 1989 Jul; 226(3):181-4. PubMed ID: 2664501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of the sunlight-exposed sample of pyrene in Salmonella typhimurium TA98.
    Takeda N; Teranishi K; Hamada K
    Bull Environ Contam Toxicol; 1984 Oct; 33(4):410-7. PubMed ID: 6386076
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo formation of mutagens by intraperitoneal administration of polycyclic aromatic hydrocarbons in animals during exposure to nitrogen dioxide.
    Miyanishi K; Kinouchi T; Kataoka K; Kanoh T; Ohnishi Y
    Carcinogenesis; 1996 Jul; 17(7):1483-90. PubMed ID: 8706253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of dipyridyls and their methylated derivatives in Salmonella typhimurium/rat liver microsome system.
    Lin JK; Huang IH; Lee KW; Lin-Shiau SY
    Proc Natl Sci Counc Repub China B; 1989 Jan; 13(1):56-63. PubMed ID: 2657826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of automobile exhausts on mutagenicity of soils: contamination with, fractionation, separation, and preliminary identification of mutagens in the Salmonella/reversion assay and effects of solvent fractions on the sister-chromatid exchanges in human lymphocyte cultures and in the in vivo mouse bone marrow micronucleus assay.
    Wesp HF; Tang X; Edenharder R
    Mutat Res; 2000 Dec; 472(1-2):1-21. PubMed ID: 11113694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and detoxification of 1,8-dinitropyrene by mammalian hepatic fractions in the Salmonella mutagenicity assay.
    Shah AB; Combes RD; Rowland IR
    Mutagenesis; 1990 Jan; 5(1):45-9. PubMed ID: 2184311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Salmonella mutagenicity test: evaluation of 29 drug candidates.
    Aaron CS; Mazurek J; Zimmer DM; Swenson DH
    Mutat Res; 1989 Jun; 223(2):171-82. PubMed ID: 2662001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.